San Diego, CA — 12/20/2017 — An investigation was announced for investors in shares of XOMA Corporation (NASDAQ:XOMA) was announced over potential breaches of fiduciary duties by certain directors at XOMA.
The investigation by a law firm concerns whether certain XOMA directors breached their fiduciary duties and caused damage to the company and its shareholders.
Emeryville, CA based XOMA Corporation is a development-stage biotechnology company that focuses on the discovery and development of monoclonal antibody-based therapeutic. XOMA Corporation reported that its annual Total Revenue declined from $55.45 million in 2015 to $5.56 million in 2016 and that its Net Loss increased from $20.61 million in 2015 to $53.53 million in 2016.
Shares of XOMA Corporation (NASDAQ:XOMA) closed on December 19, 2017 at $31.69 per share.
Those who purchased shares of XOMA Corporation (NASDAQ:XOMA), have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North – Suite 423
92108 San Diego
Latest posts by Sarah Thompson (see all)
- Born from racing: the new 2019 Porsche 911 GT3 RS - February 21, 2018
- Noitom Announces New Bundles with Perception Neuron Full Body Motion Capture and Real-Time Facial Animation Software by Facerig - February 21, 2018
- Author Henry A. Burns Promotes His Science Fiction Novel â€“ "Redemption Song" - February 21, 2018